CRFA Awards 16 New Grants and Fellowships

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

James Zoeller discussed various aspects of his cancer care after a RCC diagnosis with Hannah D. McManus, MD, and Allison Brown, BSN, RN, RN-BC.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

Lenalidomide/Dasatinib Receive FDA Approval in Hematologic Malignancies

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Lenalidomide capsules and dasatinib tablets have received FDA approval through an abbreviated new drug application for various hematologic malignancies.

Roman Fabbricatore

Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

Lenalidomide capsules and dasatinib tablets have received FDA approval through an abbreviated new drug application for various hematologic malignancies.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;David Morris, MD, MS;Tanya B. Dorff, MD;Mark T. Fleming, MD

March 5th 2025

Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies

A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.

Viviana Cortlana, PGY-4;Jade Gambill, BSc;Jenna Ghazal, BSc;Kennedy Itodo;Shreevikaa Kannan, PGY-5;Yan Leyfman, MD;Chandler H. Park, MD, FACP

Celebrating Women in Oncology Through Their Impactful Research and Insights

Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.

Ariana Pelosci

Clinicians Consider Identification, Management of RCC Through the Patient’s Eyes

For International Women's Day, CancerNetwork highlights impactful oncology research on topics from rising health care costs to innovative treatments.

Related Content

ONCOLOGY Staff

March 8th 2025

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

James Zoeller discussed various aspects of his cancer care after a RCC diagnosis with Hannah D. McManus, MD, and Allison Brown, BSN, RN, RN-BC.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

Lenalidomide/Dasatinib Receive FDA Approval in Hematologic Malignancies

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Roman Fabbricatore

Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

Lenalidomide capsules and dasatinib tablets have received FDA approval through an abbreviated new drug application for various hematologic malignancies.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;David Morris, MD, MS;Tanya B. Dorff, MD;Mark T. Fleming, MD

March 5th 2025

Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies

A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.

Viviana Cortlana, PGY-4;Jade Gambill, BSc;Jenna Ghazal, BSc;Kennedy Itodo;Shreevikaa Kannan, PGY-5;Yan Leyfman, MD;Chandler H. Park, MD, FACP

Celebrating Women in Oncology Through Their Impactful Research and Insights

Several lymphoma experts discuss the current T-cell lymphoma landscape, the need for new therapies, and ongoing research in the space.

Ariana Pelosci